Related Experiment Videos
Magnetisation transfer imaging in multiple sclerosis
1Neuroimaging Research Unit, Department of Neuroscience, Scientific Institute Ospedale San Raffaele, Via Olgettina 60, 20132 Milan, Italy.
Abstract:
Magnetisation transfer imaging (MTI) is a magnetic resonance imaging (MRI) technique that has a higher specificity than conventional T2-weighted scans to the heterogeneous pathological substrates of multiple sclerosis (MS) lesions. This review outlines the contribution of MTI in the study of lesion evolution and in the assessment of disease burden in MS. MTI studies of individual MS lesions confirm the pathological heterogeneity of T2-weighted MRI abnormalities and the potential role of unenhanced T1-weighted hypointensities as specific markers of localised severe white matter disruption. Correlative cross-sectional and longitudinal studies using MTI and gadolinium (Gd)-enhanced MRI reveal that MTI findings may vary in lesions with different patterns of enhancement, and that MTI abnormalities are closely related to the onset and recovery of blood-brain barrier disruption in new MS plaques. Measures obtained from MTI scans using whole-brain histogram analysis are highly correlated with the extent of MS abnormalities on conventional MRI scans and predict patients' clinical disability well, since they are sensitive to the amounts of both macro- and microscopic MS disease burden in the whole brain and in specific regions.
Insights
Magnetisation transfer imaging (MTI) offers higher specificity than conventional MRI for multiple sclerosis (MS) lesions. MTI accurately assesses disease burden and predicts disability by detecting macro- and microscopic damage.
Area of Science:
- Neuroimaging
- Radiology
- Neurology
Background:
- Multiple sclerosis (MS) lesions exhibit heterogeneous pathology not fully captured by conventional MRI (T2-weighted scans).
- Magnetisation transfer imaging (MTI) is a specialized MRI technique with improved specificity for MS lesion characterization.
- Understanding lesion evolution and disease burden is crucial for managing MS.
Purpose of the Study:
- To review the utility of MTI in studying MS lesion evolution.
- To assess the contribution of MTI in quantifying MS disease burden.
- To highlight MTI's role in understanding white matter disruption and blood-brain barrier dynamics in MS.
Main Methods:
- Review of existing cross-sectional and longitudinal studies utilizing MTI in MS patients.
- Correlation of MTI findings with conventional MRI (T2-weighted, T1-weighted with gadolinium enhancement).
- Analysis of MTI data using whole-brain histogram analysis to quantify disease burden.
Main Results:
- MTI confirms the pathological heterogeneity of MS lesions seen on T2-weighted MRI.
- Unenhanced T1-weighted hypointensities identified by MTI may indicate severe, localized white matter damage.
- MTI abnormalities correlate with blood-brain barrier disruption and recovery in new MS plaques.
- Whole-brain MTI histogram measures strongly correlate with conventional MRI metrics of MS burden and predict clinical disability.
Conclusions:
- MTI provides a more specific assessment of MS lesion pathology compared to conventional MRI.
- MTI is sensitive to both macro- and microscopic disease burden in MS, aiding in disability prediction.
- MTI enhances the understanding of lesion evolution, white matter integrity, and blood-brain barrier status in MS.